PRL/PRLR can substantially promote migration and invasion of T47D breast cancer cells by activating alternate downstream effectors like TEC and NEK3 kinases, leading to cytoskeletal and focal adhesion rearrangements necessary for cell adhesion and migration [47]. Here, PRL is linked to breast cancer.